During an asthma check-up at Brigham and Women's Hospital in Boston, Joel Rubinstein gets a surprising pitch — for the planet, as well as his health. His pulmonologist, Dr. Miguel Divo, explains that ...

Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...

Greenhouse gas emissions from metered-dose inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD) have increased over the past decade, resting heavily on use of just three ...

It was the respiratory therapist (RT) in charge of smoking cessation who first showed me a peak inspiratory flow meter with known resistance (PIFr). Dry-powder inhalers require inspiratory force for ...

Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase 2 trials of the drug signal, and why it shows promise for better asthma ...

Some people with chronic obstructive pulmonary disease (COPD) need to use multiple inhaled medicines each day to control their symptoms. Long-acting combination inhalers that contain more than one ...